Dry Powder Inhaler Devices Market

DelveInsight’s ‘Dry Powder Inhaler Devices -Market Insights, Competitive Landscape and Market Forecast - 2026’ report delivers an in-depth understanding of Dry Powder Inhaler Devices and the historical and forecasted Dry Powder Inhaler Devices market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.


The Dry Powder Inhaler Devices market report provides an overview of Dry Powder Inhaler Devices , as well as its PEST Analysis. Additionally, the report provides insight on the Dry Powder Inhaler Devices market share of the individual Dry Powder Inhaler Devices devices, current and forecasted Dry Powder Inhaler Devices market size from 2018 to 2026 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Dry Powder Inhaler Devices Overview

The dry powder inhaler is a medical device that is used to administer medicine efficiently to the lungs. The drug comes in dry powder form. Patients with multiple respiratory disorders use dry powder inhalers because they are compact and simple to transport. Owing to increasing incidences of asthma, lung diseases, and increasing contamination due to the high discharge of toxic chemicals, the increasing demand for dry powder inhaler (DPI) devices may be mainly attributed. These instruments are not immune to moisture and thus, once the drug comes into contact with moisture, it loses its properties. Also, the presence of other competing goods on the market, such as electric pumps and nebulizers, are the reasons that limit the development of the market.


Study Period: 2018–2026

Geography Covered

  • The US
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Japan

List of Companies:

  • Cipla Inc
  • GlaxoSmithKline Plc
  • Teicos Pharma Ltd
  • Presspart Manufacturing Ltd.
  • Beximco Pharma Ltd.
  • Catalent, Inc.
  • Hovione FarmaCiencia SA.
  • AstraZeneca Plc.
  • Bespak Europe Ltd.
  • Luckys Pharma
  • Vectura Group plc
  • Boehringer Ingelheim GmbH
  • Otsuka Pharmaceutical Co. Ltd.
  • Norton Healthcare
  • Respira Therapeutics, Inc.

Dry Powder Inhaler Devices - Competitive Analysis

This segment of the report provides a brief competitive analysis of Dry Powder Inhaler Devices , to help understand the competition in the market. It gives a comparative understanding of the products based on type.

Dry Powder Inhaler Devices : Market Segmentation

By Application

  • COPD
  • Cardiovascular diseases
  • Asthma
  • Diabetes
  • Cystic fibrosis
  • Others


By Type

  • Meterd-dose dry powder inhaler
  • Single dose dry powder inhaler


By End-user

  • Home & personal care
  • Clinics & Hospitals

Dry Powder Inhaler Devices : Market Dynamics

Market Drivers

  • Increasing incidences of respiratory & lung related diseases
  • Increasing pollution due to the high discharge of toxic chemicals
  • Increasing demand for dry powder inhaler (DPI) devices


Market Barriers

  • Instruments are not immune to moisture and thus, risk of contamination
  • Presence of alternative options, such as electric pumps and nebulizers

Dry Powder Inhaler Devices : Market Analysis

This segment illustrates the market of Dry Powder Inhaler Devices across 7MM and how the market is expected to rise in the study period (2018 to 2026), at a significant CAGR.

KOL- Views

To keep up with the market trends, we take KOLs and SME’s opinion working in Dry Powder Inhaler Devices domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Dry Powder Inhaler Devices market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.

Scope of the Report

  • The report covers the descriptive overview of Dry Powder Inhaler Devices , explaining its applications, advantages, and limitations, etc.
  • Additionally, an all-inclusive account of the currently available Dry Powder Inhaler Devices is provided, which will have an impact on the future market of Dry Powder Inhaler Devices .
  • A detailed review of Dry Powder Inhaler Devices market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the Dry Powder Inhaler Devices market.

Report Highlights

  • The report covers descriptive overview of the Dry Powder Inhaler Devices , explaining its applications, working mechanism, etc.
  • The report is a comprehensive account of marketed devices present in the Dry Powder Inhaler Devices market.
  • The report also reviews the detailed global historical and forecasted Dry Powder Inhaler Devices market including assessing the outreach in 7 MM.
  • The report helps in developing business strategies by understanding trends shaping and driving the Dry Powder Inhaler Devices market.

Dry Powder Inhaler Devices Report Key Strengths

  • 6 Years Forecast
  • 7MM Coverage
  • Competitive Landscape
  • PEST Analysis
  • Market Size

Dry Powder Inhaler Devices Report Assessment

  • Marketed Product profiles
  • Key Products and Key Players
  • Market Drivers and Barriers
  • Market Forecast
  • KOL’S views

Key Questions

Market Insights:

  • What was the Dry Powder Inhaler Devices market share (%) distribution in 2018 and how it will look like in 2026?
  • What will be the Dry Powder Inhaler Devices total market Size as well as market Size by devices across the 7MM during the forecast period (2018–2026)?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest Dry Powder Inhaler Devices market Size during the forecast period (2018–2026)?
  • At what CAGR, the Dry Powder Inhaler Devices market is expected to grow in 7MM during the forecast period (2018–2026)?
  • What will be the Dry Powder Inhaler Devices market outlook across the 7MM during the forecast period (2018–2026)?
  • What will be the Dry Powder Inhaler Devices market growth till 2026 and what will be the resultant market size in the year 2026?
  • How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?


Competitive Landscape:

  • What are the current devices available in the Dry Powder Inhaler Devices market?
  • What is the Dry Powder Inhaler Devices available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
  • How many key players are developing Dry Powder Inhaler Devices?
  • What are the key collaborations (Industry–Industry), Mergers and acquisitions, licensing activities related to the Dry Powder Inhaler Devices?
  • What are the key designations that have been granted for the current Dry Powder Inhaler Devices?
  • What are the global historical and forecasted market of Dry Powder Inhaler Devices?

Frequently Asked Questions:

What is a Dry Powder Inhaler?

The dry powder inhaler is a medical device that is used to administer medicine efficiently to the lungs. The drug comes in dry powder form. 


How is the Dry Powder Inhaler Market Segmented?

The Dry Powder Inhaler is segmented on the basis of Product Type, Channel Type and End User.


Who are the leading companies in Dry Powder Inhaler Market Landscape?

The leading companies that are working in the Dry Powder Inhaler Market are Cipla Inc, GlaxoSmithKline Plc, Teicos Pharma Ltd, Presspart Manufacturing Ltd., Beximco Pharma Ltd., Catalent, Inc. and Others


What are the Dry Powder Inhaler Market Drivers?

Some of the market drivers are increasing incidences of respiratory & lung related diseases, increasing pollution due to the high discharge of toxic chemicals and increasing demand for dry powder inhaler (DPI) devices.


What are the Dry Powder Inhaler Market Barriers?

Some of the market barriers are Instruments are not immune to moisture and thus, risk of contamination and presence of alternative options, such as electric pumps and nebulizer.


What are the key strengths of the Dry Powder Inhaler Market Report?

Key strengths of Dry Powder Inhaler Market Report are 6 Years Forecast, 7MM Coverage, Competitive Landscape, PEST Analysis, Market Size, Market Drivers and Market Barriers.


What is the Impact of Covid-19 on the Dry Powder Inhaler Market?

The Dry Powder Inhaler Market has observed a positive shift in market revenues due to the Covid 19 in 2020. The report includes the factors that are contributing to this significant increase in detail.

1. Key Insights

2. Executive Summary of Dry Powder Inhaler Devices

3. Dry Powder Inhaler Devices: Background and Overview

3.1. Introduction

4. Dry Powder Inhaler Devices: Regulatory Scenario

5. Dry Powder Inhaler Devices: Reimbursement Scenario

6. Company Profiles

6.1. Cipla Inc.

6.1.1. Company Overview

6.1.2. Product Portfolio

6.1.2.1. Product description

6.1.2.2. Regulatory Milestones

6.1.2.3. Research and Development

6.1.2.4. Product Development Activities

6.2. GlaxoSmithKline Plc.

6.2.1. Company Overview

6.2.2. Product Portfolio

6.2.2.1. Product description

6.2.2.2. Regulatory Milestones

6.2.2.3. Research and Development

6.2.2.4. Product Development Activities

Products detail in the report…

7. Dry Powder Inhaler Devices: Competitive Analysis

8. KOL Views

9. Dry Powder Inhaler Devices: Market Analysis in 7MM

9.1. Dry Powder Inhaler Devices: Market Analysis in 7MM by Application (2018–2026)

9.2. Dry Powder Inhaler Devices: Market Analysis in 7MM by Type (2018–2026)

9.3. Dry Powder Inhaler Devices: Market Analysis n 7MM by End-users (2018–2026)

10. Country-Wise Market size of Dry Powder Inhaler Devices in 7MM (2018–2026)

10.1. Market size of Dry Powder Inhaler Devices in the United States

10.1.1. Dry Powder Inhaler Devices: Market Analysis in the United State by Application (2018–2026)

10.1.2. Dry Powder Inhaler Devices: Market Analysis in the United State by Type (2018–2026)

10.1.3. Dry Powder Inhaler Devices: Market Analysis in the United State by End-users (2018–2026)

10.2. Market size of Dry Powder Inhaler Devices in France

10.2.1. Dry Powder Inhaler Devices: Market Analysis in France by Application (2018–2026)

10.2.2. Dry Powder Inhaler Devices: Market Analysis in France by Type (2018–2026)

10.2.3. Dry Powder Inhaler Devices: Market Analysis in France by End-users (2018–2026)

10.3. Market size of Dry Powder Inhaler Devices in Italy

10.3.1. Dry Powder Inhaler Devices: Market Analysis in Italy by Application (2018–2026)

10.3.2. Dry Powder Inhaler Devices: Market Analysis in Italy by Type (2018–2026)

10.3.3. Dry Powder Inhaler Devices: Market Analysis in Italy by End-users (2018–2026)

10.4. Market size of Dry Powder Inhaler Devices in the UK

10.4.1. Dry Powder Inhaler Devices: Market Analysis in the UK by Application (2018–2026)

10.4.2. Dry Powder Inhaler Devices: Market Analysis in the UK by Type (2018–2026)

10.4.3. Dry Powder Inhaler Devices: Market Analysis in the UK by End-users (2018–2026)

10.5. Market size of Dry Powder Inhaler Devices in Spain

10.5.1. Dry Powder Inhaler Devices: Market Analysis in Spain by Application (2018–2026)

10.5.2. Dry Powder Inhaler Devices: Market Analysis in Spain by Type (2018–2026)

10.5.3. Dry Powder Inhaler Devices: Market Analysis in Spain by End-users (2018–2026)

10.6. Market size of Dry Powder Inhaler Devices in Germany

10.6.1. Dry Powder Inhaler Devices: Market Analysis in Germany by Application (2018–2026)

10.6.2. Dry Powder Inhaler Devices: Market Analysis in Germany by Type (2018–2026)

10.6.3. Dry Powder Inhaler Devices: Market Analysis in Germany by End-users (2018–2026)

10.7. Market size of Dry Powder Inhaler Devices in Japan

10.7.1. Dry Powder Inhaler Devices: Market Analysis in Japan by Application (2018–2026)

10.7.2. Dry Powder Inhaler Devices: Market Analysis in Japan by Type (2018–2026)

10.7.3. Dry Powder Inhaler Devices: Market Analysis in Japan by End-users (2018–2026)

11. Market Dynamic

11.1. Market Drivers

11.2. Market Barriers

12. PEST Analysis

13. Conclusion and Future Perspective

14. Appendix

14.1. Bibliography

14.2. Report Methodology

15. DelveInsight Capabilities

16. Disclaimer

17. About DelveInsight

List of Table

Table 1: Competitive Analysis

Table 2: Dry Powder Inhaler Devices Market Analysis in the 7MM (2018–2026)

Table 3: Dry Powder Inhaler Devices Market Analysis in the 7MM by Application (2018–2026)

Table 4: Dry Powder Inhaler Devices Market Analysis in the 7MM by Type (2018–2026)

Table 5: Dry Powder Inhaler Devices Market Analysis in the 7MM by End-users (2018–2026)

Table 6: Dry Powder Inhaler Devices in the US Market Analysis (2018–2026)

Table 7: Dry Powder Inhaler Devices Market Analysis in the US by Application (2018-2026)

Table 8: Dry Powder Inhaler Devices Market Analysis in the US by Type (2018-2026)

Table 9: Dry Powder Inhaler Devices Market Analysis in the US by End-users (2018-2026)

Table 10: Dry Powder Inhaler Devices Market Analysis in Germany (2018–2026)

Table 11: Dry Powder Inhaler Devices Market Analysis in Germany by Application (2018-2026)

Table 12: Dry Powder Inhaler Devices Market Analysis in Germany by Type (2018-2026)

Table 13: Dry Powder Inhaler Devices Market Analysis in Germany by End-users (2018-2026)

Table 14: Dry Powder Inhaler Devices Market Analysis in France (2018–2026)

Table 15: Dry Powder Inhaler Devices Market Analysis in France by Application (2018-2026)

Table 16: Dry Powder Inhaler Devices Market Analysis in France by Type (2018–2026)

Table 17: Dry Powder Inhaler Devices Market Analysis in France by End-users (2018–2026)

Table 18: Dry Powder Inhaler Devices Market Analysis in Spain (2018–2026)       

Table 19: Dry Powder Inhaler Devices Market Analysis in Spain by Application (2018–2026)

Table 20: Dry Powder Inhaler Devices Market Analysis in Spain by Type (2018–2026)

Table 21: Dry Powder Inhaler Devices Market Analysis in Spain by End-users (2018–2026)

Table 22: Dry Powder Inhaler Devices Market Analysis in Italy (2018–2026)

Table 23: Dry Powder Inhaler Devices Market Analysis in Italy by Application (2018–2026)

Table 24: Dry Powder Inhaler Devices Market Analysis in Italy by Type (2018–2026)

Table 25: Dry Powder Inhaler Devices Market Analysis in Italy by End-users (2018–2026)

Table 26: Dry Powder Inhaler Devices Market Analysis in the United Kingdom (2018–2026)

Table 27: Dry Powder Inhaler Devices Market Analysis in the United Kingdom by Application (2018–2026)

Table 28: Dry Powder Inhaler Devices Market Analysis in the United Kingdom by Type (2018–2026)

Table 29: Dry Powder Inhaler Devices Market Analysis in the United Kingdom by End-users (2018–2026)

Table 30: Dry Powder Inhaler Devices Market Analysis in Japan (2018–2026)

Table 31: Dry Powder Inhaler Devices Market Analysis in Japan by Application (2018–2026)

Table 32: Dry Powder Inhaler Devices Market Analysis in Japan by Type (2018–2026)

Table 33: Dry Powder Inhaler Devices Market Analysis in Japan by End-users (2018–2026)

List of Figures

Figure 1: Product description of Dry Powder Inhaler Devices

Figure 2: Dry Powder Inhaler Devices Market Analysis in the 7MM (2018–2026)

Figure 3: Dry Powder Inhaler Devices Market Analysis in the 7MM by Type (2018–2026)

Figure 4: Dry Powder Inhaler Devices Market Analysis in the 7MM by End-users (2018–2026)

Figure 5: Dry Powder Inhaler Devices in the US (2018–2026)

Figure 6: Dry Powder Inhaler Devices Market Analysis in the US by Type (2018-2026)

Figure 7: Dry Powder Inhaler Devices Market Analysis in the US by End-users (2018-2026)

Figure 8: Dry Powder Inhaler Devices Market Analysis in Germany (2018–2026)

Figure 9: Dry Powder Inhaler Devices Market Analysis in Germany by Type (2018-2026)

Figure 10: Dry Powder Inhaler Devices Market Analysis in Germany by End-users (2018-2026)

Figure 11: Dry Powder Inhaler Devices Market Analysis in France (2018–2026)

Figure 12: Dry Powder Inhaler Devices Market Analysis in France by Type (2018–2026)

Figure 13: Dry Powder Inhaler Devices Market Analysis in France by End-users (2018–2026)

Figure 14: Dry Powder Inhaler Devices Market Analysis in Spain (2018–2026)

Figure 15: Dry Powder Inhaler Devices Market Analysis in Spain by Type (2018–2026)

Figure 16: Dry Powder Inhaler Devices Market Analysis in Spain by End-users (2018–2026)

Figure 17: Dry Powder Inhaler Devices Market Analysis in Italy (2018–2026)

Figure 18: Dry Powder Inhaler Devices Market Analysis in Italy by Type (2018–2026)

Figure 19: Dry Powder Inhaler Devices Market Analysis in Italy by End-users (2018–2026)

Figure 20: Dry Powder Inhaler Devices Market Analysis in United Kingdom (2018–2026)

Figure 21: Dry Powder Inhaler Devices Market Analysis in the United Kingdom by Type (2018–2026)

Figure 22: Dry Powder Inhaler Devices Market Analysis in the United Kingdom by End-users (2018–2026)

Figure 23: Dry Powder Inhaler Devices Market Analysis in Japan (2018–2026)       

Figure 24: Dry Powder Inhaler Devices Market Analysis in Japan by Type (2018–2026)

Figure 25: Dry Powder Inhaler Devices Market Analysis in Japan by End-users (2018–2026)

Figure 26: Market Drivers

Figure 27: Market Barriers

Cipla Inc

GlaxoSmithKline Plc

Teicos Pharma Ltd

Presspart Manufacturing Ltd.

Beximco Pharma Ltd.

Catalent, Inc.

Hovione FarmaCiencia SA.

AstraZeneca Plc.

Bespak Europe Ltd.

Luckys Pharma

Vectura Group plc

Boehringer Ingelheim GmbH

Otsuka Pharmaceutical Co. Ltd.

Norton Healthcare

Respira Therapeutics, Inc.

  • Tags:
  • Dry Powder Inhaler Devices
  • Dry Powder Inhaler Devices Mechani...
  • Dry Powder Inhaler Devices Compani...
  • Dry Powder Inhaler Devices Medical...
  • Dry Powder Inhaler Devices Market
  • Dry Powder Inhaler Devices Industr...
  • Dry Powder Inhaler Devices Market...
  • Dry Powder Inhaler Devices Market...
  • Dry Powder Inhaler Devices Compani...
  • Dry Powder Inhaler Devices devices

Forward to Friend

Need A Quote